ClinicalTrials.Veeva

Menu

The Prognostic Value of Anion Gap in Predicting Major Adverse Cardiovascular Events Among Patients With ST-Segment Elevation Myocardial Infarction (ANGIO-STEMI)

U

Universitas Diponegoro

Status

Enrolling

Conditions

ST-segment Elevation Myocardial Infarction (STEMI)

Treatments

Diagnostic Test: Anion gap

Study type

Observational

Funder types

Other

Identifiers

NCT06586424
Undip_Kardio 2

Details and patient eligibility

About

This study aims to evaluate the prognostic value of the anion gap in predicting major adverse cardiovascular events among patients with ST-segment elevation myocardial infarction. Researchers will collect information based on hospital registry as secondary data of in patient who had diagnosed as ST-segment elevation myocardial infarction and underwent primary percutaneous coronary intervention. The data consist of demographic data, clinical presentation, laboratory, and angiography result were collected from hospital registry by reviewing medical record. Then, the data was analyzed by using IBM SPSS Statistics v26.

Enrollment

80 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adults with 18 - 70 years old with diagnosis of STEMI who underwent PPCI

Exclusion criteria

  • History of heart failure due to any causes
  • Cardiogenic shock before PPCI
  • Any infection at the time of presentation
  • Pregnant woman
  • Other causes of high anion gap levels such as chronic kidney disease, metabolic acidosis, etc

Trial design

80 participants in 1 patient group

MACE group
Description:
Patient with STEMI who suffered major adverse cardiovascular events (MACE) after underwent primary percutaneous coronary intervention (PPCI)
Treatment:
Diagnostic Test: Anion gap

Trial contacts and locations

1

Loading...

Central trial contact

Leo Deddy Pradipta

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems